Skip to main content
. 2024 Jun 29;12(7):1330. doi: 10.3390/microorganisms12071330

Table 1.

Classification of successfully sequenced SARS-CoV-2 samples obtained from April 2022 to December 2023 by gender, residency, age, reason for genotyping, and vaccination status.

Total
(n = 3300)
Patient Samples per Year
2022
(n = 1798)
2023
(n = 1502)
Sex Male 1571 828 743
Female 1729 970 759
Province Perugia 2430 1364 1066
Terni 870 434 436
Age group ≤18 153 113 40
19–40 268 169 99
41–60 567 357 210
61–80 1062 537 525
>80 1250 622 628
Reason for
genotyping
ICU 99 53 46
Hospitalization 741 425 316
Immunocompromised 78 59 19
Reinfection 115 65 50
Random choice 2267 1196 1071
Vaccine doses at time of infection 0 329 207 122
1 30 19 11
2 259 154 105
3 1850 1180 670
4 571 177 394
5 15 0 15
Unknown 246 61 185